• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体系统替代途径的数学建模。

Mathematical Modelling of Alternative Pathway of Complement System.

机构信息

Division of Systems Biomedicine and Pharmacology, LACDR, Leiden University, P.O. Box 9502, 2300 RA, Leiden, The Netherlands.

Certara QSP, 4818 SJ, Breda, The Netherlands.

出版信息

Bull Math Biol. 2020 Feb 15;82(2):33. doi: 10.1007/s11538-020-00708-z.

DOI:10.1007/s11538-020-00708-z
PMID:32062771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7024062/
Abstract

The complement system (CS) is an integral part of innate immunity and can be activated via three different pathways. The alternative pathway (AP) has a central role in the function of the CS. The AP of complement system is implicated in several human disease pathologies. In the absence of triggers, the AP exists in a time-invariant resting state (physiological steady state). It is capable of rapid, potent and transient activation response upon challenge with a trigger. Previous models of AP have focused on the activation response. In order to understand the molecular machinery necessary for AP activation and regulation of a physiological steady state, we built parsimonious AP models using experimentally supported kinetic parameters. The models further allowed us to test quantitative roles played by negative and positive regulators of the pathway in order to test hypotheses regarding their mechanisms of action, thus providing more insight into the complex regulation of AP.

摘要

补体系统(CS)是先天免疫的一个组成部分,可通过三种不同途径激活。替代途径(AP)在 CS 的功能中起着核心作用。补体系统的 AP 与几种人类疾病病理有关。在没有触发物的情况下,AP 处于时间不变的静止状态(生理稳态)。它能够在受到触发物挑战时快速、有效和短暂地激活。以前的 AP 模型侧重于激活反应。为了了解 AP 激活和生理稳态调节所需的分子机制,我们使用经过实验验证的动力学参数构建了简约的 AP 模型。这些模型还使我们能够测试途径的负调节因子和正调节因子的定量作用,以测试关于它们作用机制的假设,从而更深入地了解 AP 的复杂调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/31b1c6bc4656/11538_2020_708_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/8dad6b13373c/11538_2020_708_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/5164a807f531/11538_2020_708_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/f7a350505ac1/11538_2020_708_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/e42e14e93296/11538_2020_708_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/2600f17e023d/11538_2020_708_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/6c1d7149221f/11538_2020_708_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/e9a80141908e/11538_2020_708_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/12fdd2236d69/11538_2020_708_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/56871e691294/11538_2020_708_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/31b1c6bc4656/11538_2020_708_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/8dad6b13373c/11538_2020_708_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/5164a807f531/11538_2020_708_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/f7a350505ac1/11538_2020_708_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/e42e14e93296/11538_2020_708_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/2600f17e023d/11538_2020_708_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/6c1d7149221f/11538_2020_708_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/e9a80141908e/11538_2020_708_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/12fdd2236d69/11538_2020_708_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/56871e691294/11538_2020_708_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027c/7024062/31b1c6bc4656/11538_2020_708_Fig10_HTML.jpg

相似文献

1
Mathematical Modelling of Alternative Pathway of Complement System.补体系统替代途径的数学建模。
Bull Math Biol. 2020 Feb 15;82(2):33. doi: 10.1007/s11538-020-00708-z.
2
Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.补体替代途径 C3 转化酶稳定性的稳定素结构基础。
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13504-9. doi: 10.1073/pnas.1309618110. Epub 2013 Jul 30.
3
Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.补体替代途径的激活:结合的C3b对激活物的识别以及由六种分离的蛋白质组装整个途径。
Proc Natl Acad Sci U S A. 1978 Aug;75(8):3948-52. doi: 10.1073/pnas.75.8.3948.
4
[The alternative complement pathway].[替代补体途径]
Pathol Biol (Paris). 1983 Dec;31(10):839-46.
5
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.血清备解素消耗作为C3肾小球病中C5转化酶失调的生物标志物。
Clin Exp Immunol. 2016 Apr;184(1):118-25. doi: 10.1111/cei.12754. Epub 2016 Jan 22.
6
Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.补体因子H对替代途径C3前转化酶和C3转化酶组装及衰变影响的见解
J Biol Chem. 2016 Apr 8;291(15):8214-30. doi: 10.1074/jbc.M115.693119. Epub 2016 Feb 22.
7
The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).重温周转理论:可溶性替代补体C3转化酶(C3(H2O)Bb)的形成与调节
Mol Immunol. 2008 Apr;45(8):2370-9. doi: 10.1016/j.molimm.2007.11.003. Epub 2007 Dec 21.
8
A small fragment of factor B as a potential inhibitor of complement alternative pathway activity.因子 B 的一小片段作为补体替代途径活性的潜在抑制剂。
Immunobiology. 2021 Jul;226(4):152106. doi: 10.1016/j.imbio.2021.152106. Epub 2021 Jun 16.
9
Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b.一种识别C3b/iC3b的单克隆抗体对补体替代途径的选择性高效抑制作用
Mol Immunol. 2006 Mar;43(7):1010-9. doi: 10.1016/j.molimm.2005.05.003. Epub 2005 Jun 14.
10
A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.一种新型抗人备解素抗体可抑制替代补体系统,并能特异性检测血样中的备解素。
PLoS One. 2014 May 5;9(5):e96371. doi: 10.1371/journal.pone.0096371. eCollection 2014.

引用本文的文献

1
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study.ALXN1820(Tarperprumig)在健康成年人中的安全性、耐受性、药代动力学、药效学及免疫原性:一项I期研究的结果
Clin Transl Sci. 2025 Apr;18(4):e70190. doi: 10.1111/cts.70190.
2
Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.从系统免疫学角度解析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对止血和补体系统的影响
Front Immunol. 2025 Jan 13;15:1457324. doi: 10.3389/fimmu.2024.1457324. eCollection 2024.
3
De-stabilizing innate immunity in COVID-19: effects of its own positive feedback and erratic viraemia on the alternative pathway of complement.

本文引用的文献

1
Self versus Nonself Discrimination by the Soluble Complement Regulators Factor H and FHL-1.可溶性补体调节因子 H 和 FHL-1 的自我与非我识别。
J Immunol. 2019 Apr 1;202(7):2082-2094. doi: 10.4049/jimmunol.1801545. Epub 2019 Feb 11.
2
Properdin: A multifaceted molecule involved in inflammation and diseases.备解素:一种参与炎症和疾病的多功能分子。
Mol Immunol. 2018 Oct;102:58-72. doi: 10.1016/j.molimm.2018.05.018. Epub 2018 Jun 27.
3
A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention.
新冠病毒感染中先天免疫的不稳定:其自身正反馈和不稳定病毒血症对补体替代途径的影响
R Soc Open Sci. 2024 Jan 17;11(1):221597. doi: 10.1098/rsos.221597. eCollection 2024 Jan.
4
Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection.补体系统信号通路的建模与分析:C3、C5a 和促炎细胞因子在 SARS-CoV-2 感染中的作用。
PeerJ. 2023 Sep 20;11:e15794. doi: 10.7717/peerj.15794. eCollection 2023.
5
Vitamin D deficiency leads to the abnormal activation of the complement system.维生素 D 缺乏会导致补体系统异常激活。
Immunol Res. 2023 Feb;71(1):29-38. doi: 10.1007/s12026-022-09324-6. Epub 2022 Sep 30.
6
Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens.免疫易感病原体下补体系统的系统生物学建模
Front Phys. 2021 Apr 29;9. doi: 10.3389/fphy.2021.603704.
7
Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease.建模补体旁路途径的激活及其在健康和疾病中对溶血的影响。
PLoS Comput Biol. 2020 Oct 2;16(10):e1008139. doi: 10.1371/journal.pcbi.1008139. eCollection 2020 Oct.
一种用于评估补体系统在稳态、疾病和药物干预下的调节作用的计算模型。
PLoS One. 2018 Jun 6;13(6):e0198644. doi: 10.1371/journal.pone.0198644. eCollection 2018.
4
Reduced order modeling and analysis of the human complement system.人类补体系统的降阶建模与分析
PLoS One. 2017 Nov 20;12(11):e0187373. doi: 10.1371/journal.pone.0187373. eCollection 2017.
5
Properdin: a tightly regulated critical inflammatory modulator.备解素:一种受到严格调控的关键炎症调节因子。
Immunol Rev. 2016 Nov;274(1):172-190. doi: 10.1111/imr.12466.
6
Quantitative Modeling of the Alternative Pathway of the Complement System.补体系统替代途径的定量建模
PLoS One. 2016 Mar 31;11(3):e0152337. doi: 10.1371/journal.pone.0152337. eCollection 2016.
7
Comparative Analysis of Novel Complement-Targeted Inhibitors, MiniFH, and the Natural Regulators Factor H and Factor H-like Protein 1 Reveal Functional Determinants of Complement Regulation.新型补体靶向抑制剂、微型补体调节蛋白FH以及天然调节因子H和类补体调节蛋白1的比较分析揭示了补体调节的功能决定因素。
J Immunol. 2016 Jan 15;196(2):866-76. doi: 10.4049/jimmunol.1501919. Epub 2015 Dec 7.
8
Complement, a target for therapy in inflammatory and degenerative diseases.补体,炎症和退行性疾病的治疗靶点。
Nat Rev Drug Discov. 2015 Dec;14(12):857-77. doi: 10.1038/nrd4657. Epub 2015 Oct 23.
9
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy.一种延长型微小补体因子H分子可改善实验性C3肾小球病。
Kidney Int. 2015 Dec;88(6):1314-1322. doi: 10.1038/ki.2015.233. Epub 2015 Jul 29.
10
Properdin levels in human sepsis.人类脓毒症中的备解素水平。
Front Immunol. 2015 Feb 2;6:24. doi: 10.3389/fimmu.2015.00024. eCollection 2015.